Catecholamines and Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury

Paroxysmal sympathetic hyperactivity (PSH) affects a significant minority of people in the intensive care unit after severe traumatic brain injury. Systematic research has yet to elucidate or quantify the extent of the role of the catecholamines or adrenocortical and thyroid axis hormonal influences...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurotrauma Vol. 34; no. 1; pp. 109 - 114
Main Authors Fernandez-Ortega, Juan F., Baguley, Ian J., Gates, Thomas A., Garcia-Caballero, Manuel, Quesada-Garcia, Juan G., Prieto-Palomino, Miguel A.
Format Journal Article
LanguageEnglish
Published United States Mary Ann Liebert, Inc 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Paroxysmal sympathetic hyperactivity (PSH) affects a significant minority of people in the intensive care unit after severe traumatic brain injury. Systematic research has yet to elucidate or quantify the extent of the role of the catecholamines or adrenocortical and thyroid axis hormonal influences in the condition. Data were prospectively collected on 80 consecutive patients, 18 of whom developed clinical signs of PSH (22.5%). Catecholamine and hormonal data were collected sequentially at 4-h intervals or during and between episodes of PSH. Evaluated variables showed 200-300% increases in catecholamines and, to a lesser extent, adrenocortical hormones during paroxysms. The majority of PSH episodes (72%) were noted to be in response to an observable triggering event. These changes were not observed in subjects without PSH. These data go some way to explain why PSH produces adverse consequences in survivors of TBI with the condition.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0897-7151
1557-9042
1557-9042
DOI:10.1089/neu.2015.4364